LAKE FOREST, Ill., Aug. 30, 2012 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today announced a change in date for the company's presentation at the UBS Global Life Sciences Conference from Wednesday, Sept. 19, 2012 to Thursday, Sept. 20, 2012, in New York.
The presentation is scheduled to begin at 11:00 a.m. Eastern time on Thursday, Sept. 20, 2012. It will be available to all interested parties through a live audiocast accessible via the investor relations section of Hospira's website at www.hospirainvestor.com. Listeners should log on approximately 10 minutes in advance to ensure proper setup to receive the audiocast. A replay of the webcast will be available on the Hospira website approximately 24 hours after the live presentation for 30 days after the event.
About HospiraHospira, Inc. is the world's leading provider of injectable drugs and infusion technologies. Through its broad, integrated portfolio, Hospira is uniquely positioned to Advance Wellness™ by improving patient and caregiver safety while reducing healthcare costs. The company is headquartered in Lake Forest, Ill., and has approximately 15,000 employees. Learn more at www.hospira.com.
SOURCE Hospira, Inc.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts